Wisel Camela 4/A
4/A · Chemours Co · Filed Mar 10, 2023
Insider Transaction Report
Form 4/AAmended
Wisel Camela
VP, CAO & Controller
Transactions
- Award
Performance Stock Option (Right to Buy)
2023-03-01+5,010→ 5,010 totalExercise: $38.32Exp: 2033-03-01→ Common Stock (5,010 underlying)
Footnotes (3)
- [F1]Represents a 10 percent premium above the closing price of the Company common stock on the date of grant
- [F2]The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.
- [F3]These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.